These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3290470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S, Heinrich M, Sonntag JM, Krauss J.
    Eur J Pharmacol; 1986 Oct 07; 129(3):367-70. PubMed ID: 3536532
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR.
    Eur J Pharmacol; 1992 Jan 21; 210(3):279-84. PubMed ID: 1351844
    [Abstract] [Full Text] [Related]

  • 4. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD, Ford D, Duffy RA, Chipkin RE, Iorio LC, Barnett A.
    Life Sci; 1988 Jan 21; 43(23):1861-9. PubMed ID: 2904635
    [Abstract] [Full Text] [Related]

  • 5. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
    Cross AJ, Mashal RD, Johnson JA, Owen F.
    Neuropharmacology; 1983 Nov 21; 22(11):1327-9. PubMed ID: 6141534
    [Abstract] [Full Text] [Related]

  • 6. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun 21; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 7. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 8. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE, Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):339-42. PubMed ID: 6150862
    [Abstract] [Full Text] [Related]

  • 9. The binding of SCH 39166 and SCH 23390 to 5-HT1C receptors in porcine choroid plexus.
    Taylor LA, Tedford CE, McQuade RD.
    Life Sci; 1991 Oct 15; 49(20):1505-11. PubMed ID: 1943454
    [Abstract] [Full Text] [Related]

  • 10. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH, Nielsen EB.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 15; 59(4):315-8. PubMed ID: 2948372
    [Abstract] [Full Text] [Related]

  • 11. SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.
    Skarsfeldt T, Larsen JJ.
    Eur J Pharmacol; 1988 Apr 13; 148(3):389-95. PubMed ID: 2968272
    [Abstract] [Full Text] [Related]

  • 12. Effects of D-5-hydroxytryptophan and D-DOPA on binding at serotonin and dopamine receptors.
    Acton G.
    Res Commun Chem Pathol Pharmacol; 1988 Apr 13; 60(1):129-32. PubMed ID: 3132733
    [Abstract] [Full Text] [Related]

  • 13. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
    Arnt J, Hyttel J, Larsen JJ.
    Acta Pharmacol Toxicol (Copenh); 1984 Nov 13; 55(5):363-72. PubMed ID: 6152104
    [Abstract] [Full Text] [Related]

  • 14. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD, Duffy RA, Coffin VL, Chipkin RE, Barnett A.
    J Pharmacol Exp Ther; 1991 Apr 13; 257(1):42-9. PubMed ID: 1826927
    [Abstract] [Full Text] [Related]

  • 15. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
    McQuade RD, Duffy RA, Anderson CC, Crosby G, Coffin VL, Chipkin RE, Barnett A.
    J Neurochem; 1991 Dec 13; 57(6):2001-10. PubMed ID: 1834801
    [Abstract] [Full Text] [Related]

  • 16. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
    Berzétei IP, Bagdy E, Hardy M, Borsy J.
    Pol J Pharmacol Pharm; 1985 Dec 13; 37(3):237-42. PubMed ID: 4070077
    [Abstract] [Full Text] [Related]

  • 17. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.
    Bonhomme N, Cador M, Stinus L, Le Moal M, Spampinato U.
    Brain Res; 1995 Mar 27; 675(1-2):215-23. PubMed ID: 7796132
    [Abstract] [Full Text] [Related]

  • 18. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J.
    Brain Res; 1997 May 16; 757(1):17-23. PubMed ID: 9200494
    [Abstract] [Full Text] [Related]

  • 19. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Jul 07; 415(1):90-7. PubMed ID: 2957025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.